Clinical Trials
12 trialsNCT03093116 2026-05-27
TRIDENT-1
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT06119581 2026-05-19
SUNRAY-01
Eli Lilly and Company
Phase 3 Recruiting
NCT07185997 2026-05-11
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
ArriVent BioPharma, Inc.
Phase 3 Recruiting
NCT07242547 2026-05-05
MERLIN
Fundación GECP
Phase 2 Recruiting
NCT05297734 2026-04-30
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Phase NA Recruiting
NCT06128551 2026-04-23
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Revolution Medicines, Inc.
Phase 1/2 Recruiting
NCT03803787 2026-04-08
Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
Instituto Nacional de Cancerologia de Mexico
Phase 2 Recruiting
NCT02984761 2026-02-19
VALOR
VA Office of Research and Development
Phase NA Recruiting
NCT07165691 2025-12-02
TELESCOPE-H
Rutgers, The State University of New Jersey
Phase NA Recruiting
NCT06917573 2025-11-19
PALACE
Fundación GECP
Phase 2 Recruiting
NCT06988943 2025-05-30
Early Intervention Strategies for Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University
Phase NA Recruiting
NCT06177925 2023-12-20
A Phase â…¡ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
Nanfang Hospital, Southern Medical University
Phase 2 Recruiting